Skip to main content
Top
Published in: Sleep and Breathing 1/2021

01-03-2021 | Coronary Heart Disease | Sleep Breathing Physiology and Disorders • Original Article

Hypoxemic features of obstructive sleep apnea and the risk of mortality: a cluster analysis

Authors: Gonzalo Labarca, Jorge Jorquera, Jorge Dreyse, Constanza Salas, Francisca Letelier

Published in: Sleep and Breathing | Issue 1/2021

Login to get access

Abstract

Introduction

Patients with moderate to severe obstructive sleep apnea (OSA) have an increased risk of cardiovascular comorbidities and mortality. Although different subtypes of OSA have been described, data about oximetric parameters and their suitability to identify a different phenotype are scant. In this study, we evaluate the association between moderate to severe OSA and oximetric parameters included in the home sleep apnea test (HSAT) and the risks of all-cause mortality, cardiovascular mortality, and cancer mortality.

Methods

Adult patients with moderate to severe OSA from a clinical cohort in Chile were included (SantOSA study). We developed a latent class analysis (LCA) incorporating oximetric measures commonly reported on HSAT. Differences between the groups were evaluated using ANOVA and the chi-squared test. Survival curves were constructed using a Kaplan-Meier (log-rank) model, and adjusted hazard ratios of mortality were calculated using a Cox regression model following a confounder analysis of cardiovascular comorbidities.

Results

A total of 889 patients were included in the analysis. LCA identified three different clusters: Cluster 1, “nonhypoxemic” (n = 591); cluster 2, “moderately hypoxemic” (n = 297); and cluster 3, “severely hypoxemic” (n = 115). The mean follow-up was 4.7 years. The hypoxemic groups showed an increased risk of cardiometabolic comorbidities and an independent risk of all-cause mortality (adjusted HR 1.67 (CI 1.0–2.64) p value = 0.027). The moderately hypoxemic group had an adjusted HR of 2.92 (CI 1.00–8.58), p value = 0.05, while the severely hypoxemic group had an adjusted HR of 2.55 (CI 1.08–6.02), p value = 0.031. For cardiovascular mortality, we found an HR of 2.03 (CI 0.50–8.136), p value = 0.31, and for cancer mortality, we found an HR of 5.75 (CI 1.03–32.17), p value = 0.042.

Conclusion

Oximetric parameters are useful for describing a different phenotype with a high risk of mortality among patients with moderate to severe OSA, beyond the apnea–hypopnea index.
Appendix
Available only for authorised users
Literature
1.
go back to reference Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7(8):687–698CrossRef Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7(8):687–698CrossRef
2.
go back to reference Labarca G, Cruz NR, Descalzi F (2014) Multisystemic involvement in obstructive sleep apnea. Rev Med Chil 142(6):748–757CrossRef Labarca G, Cruz NR, Descalzi F (2014) Multisystemic involvement in obstructive sleep apnea. Rev Med Chil 142(6):748–757CrossRef
3.
go back to reference Veasey SC, Rosen IM (2019) Obstructive sleep apnea in adults. N Engl J Med 380(15):1442–1449CrossRef Veasey SC, Rosen IM (2019) Obstructive sleep apnea in adults. N Engl J Med 380(15):1442–1449CrossRef
4.
go back to reference Qaseem A, Dallas P, Owens DK, Starkey M, Holty JE, Shekelle P, Clinical Guidelines Committee of the American College of Physicians (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161(3):210–220CrossRef Qaseem A, Dallas P, Owens DK, Starkey M, Holty JE, Shekelle P, Clinical Guidelines Committee of the American College of Physicians (2014) Diagnosis of obstructive sleep apnea in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 161(3):210–220CrossRef
6.
go back to reference Ye L, Pien GW, Ratcliffe SJ, Bjornsdottir E, Arnardottir ES, Pack AI et al (2014) The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 44(6):1600–1607CrossRef Ye L, Pien GW, Ratcliffe SJ, Bjornsdottir E, Arnardottir ES, Pack AI et al (2014) The different clinical faces of obstructive sleep apnoea: a cluster analysis. Eur Respir J 44(6):1600–1607CrossRef
9.
go back to reference Punjabi NM (2016) COUNTERPOINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? No Chest 149(1):16–19CrossRef Punjabi NM (2016) COUNTERPOINT: is the apnea-hypopnea index the best way to quantify the severity of sleep-disordered breathing? No Chest 149(1):16–19CrossRef
10.
go back to reference Stamatakis K, Sanders MH, Caffo B, Resnick HE, Gottlieb DJ, Mehra R, Punjabi NM (2008) Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep. 31(7):1018–1024PubMedPubMedCentral Stamatakis K, Sanders MH, Caffo B, Resnick HE, Gottlieb DJ, Mehra R, Punjabi NM (2008) Fasting glycemia in sleep disordered breathing: lowering the threshold on oxyhemoglobin desaturation. Sleep. 31(7):1018–1024PubMedPubMedCentral
11.
go back to reference Butler MP, Emch JT, Rueschman M, Sands SA, Shea SA, Wellman A, Redline S (2019) Apnea-hypopnea event duration predicts mortality in men and women in the Sleep Heart Health Study. Am J Respir Crit Care Med 199(7):903–912CrossRef Butler MP, Emch JT, Rueschman M, Sands SA, Shea SA, Wellman A, Redline S (2019) Apnea-hypopnea event duration predicts mortality in men and women in the Sleep Heart Health Study. Am J Respir Crit Care Med 199(7):903–912CrossRef
12.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening The Reporting Of Observational Studies In Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296CrossRef von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening The Reporting Of Observational Studies In Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4(10):e296CrossRef
13.
go back to reference Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 14(6):540–545CrossRef Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 14(6):540–545CrossRef
14.
15.
go back to reference Flemons WW (2002) Clinical practice. Obstructive sleep apnea. N Engl J Med 347(7):498–504CrossRef Flemons WW (2002) Clinical practice. Obstructive sleep apnea. N Engl J Med 347(7):498–504CrossRef
16.
go back to reference Chung F, Abdullah HR, Liao P (2016) STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 149(3):631–638CrossRef Chung F, Abdullah HR, Liao P (2016) STOP-Bang questionnaire: a practical approach to screen for obstructive sleep apnea. Chest. 149(3):631–638CrossRef
17.
go back to reference Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13(3):479–504CrossRef Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG (2017) Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13(3):479–504CrossRef
18.
go back to reference Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet. 360(9328):237–245CrossRef Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet. 360(9328):237–245CrossRef
19.
go back to reference Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology. 17(2):223–236CrossRef Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology. 17(2):223–236CrossRef
20.
go back to reference Vicente E, Marin JM, Carrizo SJ, Osuna CS, Gonzalez R, Marin-Oto M et al (2016) Upper airway and systemic inflammation in obstructive sleep apnoea. Eur Respir J 48(4):1108–1117CrossRef Vicente E, Marin JM, Carrizo SJ, Osuna CS, Gonzalez R, Marin-Oto M et al (2016) Upper airway and systemic inflammation in obstructive sleep apnoea. Eur Respir J 48(4):1108–1117CrossRef
22.
go back to reference Feng J, Zhang D, Chen B (2012) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16(2):283–294CrossRef Feng J, Zhang D, Chen B (2012) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath 16(2):283–294CrossRef
23.
go back to reference Kaczmarek E, Bakker JP, Clarke DN, Csizmadia E, Kocher O, Veves A, Tecilazich F, O'Donnell CP, Ferran C, Malhotra A (2013) Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One 8(7):e70559CrossRef Kaczmarek E, Bakker JP, Clarke DN, Csizmadia E, Kocher O, Veves A, Tecilazich F, O'Donnell CP, Ferran C, Malhotra A (2013) Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One 8(7):e70559CrossRef
24.
go back to reference Yilmaz Avci A, Avci S, Lakadamyali H, Can U (2017) Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups. Sleep Breath 21(3):703–711CrossRef Yilmaz Avci A, Avci S, Lakadamyali H, Can U (2017) Hypoxia and inflammation indicate significant differences in the severity of obstructive sleep apnea within similar apnea-hypopnea index groups. Sleep Breath 21(3):703–711CrossRef
25.
go back to reference Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 365(9464):1046–1053CrossRef Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 365(9464):1046–1053CrossRef
26.
go back to reference Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, Redline S, Wellman A (2019) The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study. Eur Heart J 40(14):1149–1157CrossRef Azarbarzin A, Sands SA, Stone KL, Taranto-Montemurro L, Messineo L, Terrill PI, Ancoli-Israel S, Ensrud K, Purcell S, White DP, Redline S, Wellman A (2019) The hypoxic burden of sleep apnoea predicts cardiovascular disease-related mortality: the osteoporotic fractures in men study and the sleep heart health study. Eur Heart J 40(14):1149–1157CrossRef
27.
go back to reference Martinez-Garcia MA, Campos-Rodriguez F, Barbe F, Gozal D, Agusti A (2019) Precision medicine in obstructive sleep apnoea. Lancet Respir Med 7(5):456–464CrossRef Martinez-Garcia MA, Campos-Rodriguez F, Barbe F, Gozal D, Agusti A (2019) Precision medicine in obstructive sleep apnoea. Lancet Respir Med 7(5):456–464CrossRef
29.
go back to reference Kim J, Keenan BT, Lim DC, Lee SK, Pack AI, Shin C (2018) Symptom-based subgroups of Koreans with obstructive sleep apnea. J Clin Sleep Med 14(3):437–443CrossRef Kim J, Keenan BT, Lim DC, Lee SK, Pack AI, Shin C (2018) Symptom-based subgroups of Koreans with obstructive sleep apnea. J Clin Sleep Med 14(3):437–443CrossRef
30.
go back to reference Labarca G, Dreyse J, Salas C, Gaete MI, Jorquera J (2019) Performance of instruments aimed at detecting obstructive sleep apnea syndrome among individuals in Chile. J Bras Pneumol 46(1):e20190015CrossRef Labarca G, Dreyse J, Salas C, Gaete MI, Jorquera J (2019) Performance of instruments aimed at detecting obstructive sleep apnea syndrome among individuals in Chile. J Bras Pneumol 46(1):e20190015CrossRef
31.
go back to reference Zinchuk AV, Jeon S, Koo BB, Yan X, Bravata DM, Qin L, Selim BJ, Strohl KP, Redeker NS, Concato J, Yaggi HK (2018) Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea. Thorax. 73(5):472–480CrossRef Zinchuk AV, Jeon S, Koo BB, Yan X, Bravata DM, Qin L, Selim BJ, Strohl KP, Redeker NS, Concato J, Yaggi HK (2018) Polysomnographic phenotypes and their cardiovascular implications in obstructive sleep apnoea. Thorax. 73(5):472–480CrossRef
Metadata
Title
Hypoxemic features of obstructive sleep apnea and the risk of mortality: a cluster analysis
Authors
Gonzalo Labarca
Jorge Jorquera
Jorge Dreyse
Constanza Salas
Francisca Letelier
Publication date
01-03-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 1/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02064-7

Other articles of this Issue 1/2021

Sleep and Breathing 1/2021 Go to the issue

Epidemiology • Letter to the Editors

Insomnia and type 2 diabetes mellitus: a risk assessment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.